Drawing for REXCURE

USPTO serial 79201842

REXCURE

Reviewed by CopyMark Law Group

Reg. 5372129Status 709
Filing date
Status date
Registration date
Jan 9, 2018
Examiner
PARKS, KIMBERLY L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with REXCURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Boryana Arsova

Boryana Arsova Martensen Wright PCOne Capitol Mall, Suite 670Sacramento, CA 95814

Goods and services

ClassDescriptionStatusFirst use
005Herbal, homeopathic and pharmaceutical preparations, medicines and diet supplements, namely, sprays, creams, ointments, drinkable liquids, powder, tablets and suppository pills containing herbal and pharmaceutical extracts to be used for medical purposes, namely, the treatment and relief of, skin rash, sun rash, skin itching, eczema, swollen and irritated skin, spots, pimples, acne, allergies, insect stings and bites; animal repellents for the use on humans, animals and plants, namely, sprays, creams, ointments, drinkable liquids, powder, tablets and suppository pills containing herbal and pharmaceutical extracts to be used as a repellent against insects, namely, lice, fleas, mosquitoes, hornets, bees and fliesSECTION 71 - CANCELLED—
042Basic and clinical research, as well as development of pharmaceutical preparations, medicines and diet supplements, in the field of herbal, homeopathic and pharmaceutical medicine, namely, for the use in the treatment and relief of, skin rash, sun rash, skin itching, eczema, swollen and irritated skin, spots, pimples, acne, allergies, insect stings and bites; basic and clinical research, as well as development of pharmaceutical preparations and medicines, in the field of herbal, homeopathic and pharmaceutical medicine, namely, the research and development of animal repellents for the use on humans, animals and plants, namely, sprays, creams, ointments, drinkable liquids, powder, tablets and suppository pills containing herbal and pharmaceutical extracts to be used as a repellent against insectsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 3, 2025Further Decision Processed by IB—
Sep 4, 2025XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Sep 3, 2025INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Sep 3, 2025XXCRGENERIC MADRID TRANSACTION CREATED—
Mar 26, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 26, 2024C71TCANCELLED SECTION 71—
Jan 9, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 25, 2018FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 17, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 17, 2018FIMPFINAL DISPOSITION PROCESSED—
Apr 9, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 9, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 17, 2017GPNXNOTIFICATION PROCESSED BY IB—
Oct 24, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 24, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 4, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 4, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 4, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 12, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 31, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 30, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 30, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 21, 2017RFNTREFUSAL PROCESSED BY IB—
Mar 1, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 1, 2017RFRRREFUSAL PROCESSED BY MPU—
Feb 28, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 28, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 27, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2017DOCKASSIGNED TO EXAMINER—
Feb 22, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 17, 2017LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Feb 16, 2017SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance